CD160 receptor in CLL: Current state and future avenues

CD160 is a glycosylphosphatidylinositol (GPI)-anchored cell surface glycoprotein expressed on cytotoxic natural killer (NK) cells and T-cell subsets. It plays a crucial role in the activation of NK-cell cytotoxicity and cytokine production. It also modulates the immune system and is involved in some...

Descripción completa

Detalles Bibliográficos
Autores principales: Oumeslakht, Loubna, Aziz, Abdel-ilah, Bensussan, Armand, Ben Mkaddem, Sanae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676924/
https://www.ncbi.nlm.nih.gov/pubmed/36420268
http://dx.doi.org/10.3389/fimmu.2022.1028013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676924/
https://www.ncbi.nlm.nih.gov/pubmed/36420268
http://dx.doi.org/10.3389/fimmu.2022.1028013

Ejemplares similares